Huahui Health
Clinical trials sponsored by Huahui Health, explained in plain language.
-
New antibody shows promise against Hard-to-Treat hepatitis delta
Disease control CompletedThis study tested an experimental drug called HH-003 in 101 adults with chronic hepatitis delta, a serious liver infection. The drug is an antibody that targets the hepatitis B virus, which the delta virus needs to survive. The main goal was to see if HH-003 could lower the amoun…
Phase: PHASE2 • Sponsor: Huahui Health • Aim: Disease control
Last updated May 26, 2026 05:51 UTC
-
New hepatitis b drug shows promise in early safety trial
Disease control CompletedThis early-stage study tested a new drug called HH-006 in 36 adults with untreated chronic hepatitis B. The goal was to check if the drug is safe and how the body processes it. Participants received either the drug or a placebo, and researchers monitored side effects and antivira…
Phase: PHASE1 • Sponsor: Huahui Health • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New antibody HH-101 tested for safety in advanced cancer patients
Disease control CompletedThis early-phase study tested the safety of a new antibody drug called HH-101 in 12 adults with advanced solid tumors that had not responded to other treatments. The main goal was to see what side effects occurred and find a safe dose. Researchers also looked for early signs that…
Phase: PHASE1 • Sponsor: Huahui Health • Aim: Disease control
Last updated May 13, 2026 16:03 UTC